Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University24 enrolled

Overview

This pilot early phase I trial studies the Automated Device for Asthma Monitoring and Management in monitoring adult patients with lung cancer who are undergoing radiation therapy. The Automated Device for Asthma Monitoring and Management may provide useful information to doctors to help monitor adult patients with lung cancer and diagnose certain conditions earlier than traditional means.

PRIMARY OBJECTIVES: I. Determine compliance with the Automated Device for Asthma Monitoring and Management (ADAMM) device in patients receiving radiation therapy (RT) for lung cancer. SECONDARY OBJECTIVES: I. Evaluate feasibility of recruitment, acceptability of the ADAMM device, and compliance with electronic patient-reported outcomes (ePROs) in this patient population

Study Type

OBSERVATIONAL

Enrollment

Conditions

Lung Carcinoma

Interventions

Monitoring DeviceDEVICE

Wear ADAMM

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients are capable of giving informed consent * Patients are eligible to be treated with RT and plan to start treatment * Patients have either metastatic or non-metastatic lung cancer as defined in history and physical * Patients must be able to read or speak English * Women of reproductive potential should have a negative serum or urine pregnancy test within one week prior to radiation planning CT scan Exclusion Criteria: * Patients who cannot read or speak English * Patients who are not candidates for RT treatment * Women of childbearing potential who are pregnant or breastfeeding

Locations (1)

Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Percentage of hours per day that patients wear the Automated Device for Asthma Monitoring and Management device

The compliance rate along with a one-sided exact 95% confidence interval will be estimated.

Time frame: Up to 4 weeks post-radiation therapy

Percentage of days per study period that patients wear the Automated Device for Asthma Monitoring and Management device

The compliance rate along with a one-sided exact 95% confidence interval will be estimated.

Time frame: Up to 4 weeks post-radiation therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.